| Literature DB >> 31807922 |
Sarah Péricart1,2, Charlotte Waysse3, Aurore Siegfried4,5, Stephanie Struski6, Eric Delabesse7, Camille Laurent4,5,8, Solène Evrard4,5,8.
Abstract
Histiocytic sarcoma (HS) is a rare aggressive hematologic neoplasm that can be associated with low-grade B cell lymphoma. The development of both neoplasms is currently being considered a transdifferentiation mechanism but remains elusive. We report the case of a 65-year-old patient with synchronous development of peritoneal/abdominal HS and grade 1-2 follicular lymphoma (FL). Cytogenetic analysis and targeted next-generation sequencing of both FL and HS tumors identified common genomic alterations such as IGH-BCL2 rearrangement, CREBBP and KMT2D, and aberrations of chromosomes 9q and 19q. However, only the HS tumor had a KRAS mutation while the lymph node involved by FL harbored a TNFAIP3 mutation and both tumors also showed distinct chromosomal alterations. This report strengthens the hypothesis of a common lymphoid progenitor which accumulates genetic alterations leading to two different hematologic malignant diseases with significantly distinct prognoses.Entities:
Keywords: Follicular lymphoma; Histiocytic sarcoma; Targeted next-generation DNA sequencing; Transdifferentiation
Mesh:
Substances:
Year: 2019 PMID: 31807922 DOI: 10.1007/s00428-019-02691-w
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064